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Abstract
Background: Extraintestinal manifestations of Crohn's disease may involve the skin, the eyes, the
genital mucosa, and the joints. Dermatoses associated with Crohn's disease include neutrophilic
dermatoses, erythema nodosum, granulomatous dermatitis, blistering dermatoses, and non-specific
skin manifestations. Cutaneous Crohn's disease is characterized by skin non-caseating epithelioid
granulomatas with giant cells, remote from the gastrointestinal tract. We report herein two new
cases.
Observations: On both patients, differential diagnosis of neutrophilic dermatoses and infectious
disease were evoked, and antimicrobial agents were introduced in one of them. Given the atypical
presentation, the final diagnosis of cutaneous Crohn's disease could only be made with histological
examination. In patient 1, the plaques decreased in size and infiltration by more than 75% after 3
weeks of treatment with bethametasone dipropionate 0.05% cream. In patient 2, the plaques
decreased by more than 50% after 6 weeks of treatment with prednisolone (45 mg/day) and
azathioprine (100 mg/day).
Discussion: Cutaneous Crohn's disease may present as dusky, erythematous, infiltrated, and
ulcerated plaques and nodules. Female-to-male sex ratio is about 2, and the mean age at onset is
35. Recurrently, the hypothesis of a skin mycobacterial or fungal infection greatly delays proper
treatment. Rarity of cutaneous Crohn's disease hampers therapeutic assessment in controlled
trials. Thus, available literature is limited to case reports and sparse small series, with contradictory
results. These reports are subject to publication bias, and no definite evidence-based
recommendations can be made on the most adequate therapeutic strategy.
Background
Crohn's disease is characterized by a chronic relapsing
transmural granulomatous inflammation that may
involve any part of the digestive tract from mouth to anus,
though mostly found in the ileum, the cecum, and the
colon. It involves a type-1 helper T lymphocytes – medi-
ated immune reaction of unknown etiology, which may
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result from an interaction between environmental factors
such as enteric bacteria, and a genetic susceptibility [1,2].
Extraintestinal manifestations of Crohn's disease may
involve the eyes, the skin, the genital mucosa, and the
joints. Associated distant skin manifestations are poly-
morphous, and occur in 14 to 44% of patients with
Crohn's disease [3,4]. They can be classified in two catego-
ries depending on whether they are a direct ("metastatic")
manifestation of the granulomatous disease or simply
associated with it. The range of skin manifestations asso-
ciated with Crohn's disease includes neutrophilic derma-
toses such as pyoderma gangrenosum and Sweet's
syndrome, various panniculitis such as erythema nodo-
sum, granulomatous dermatitis exemplified by palisading
granulomatous dermatitis and necrobiosis lipoidica [5],
blistering dermatoses such as epidermolysis bullosa
acquisita and erythema multiform, and non-specific skin
manifestations such as adverse drug reactions and malab-
sorption-associated dermatologic changes.
Cutaneous Crohn's disease, also called metastatic Crohn's
disease, is a rare manifestation characterized by a promi-
nent non-caseating granulomatous inflammation devel-
oping in the skin. This manifestation is by definition
remotely located from the gastrointestinal tract with non
specific clinical features, and often misleads clinicians and
delays adequate therapy [6]. We report herein two cases of
cutaneous Crohn's disease located on the legs.
Patient 1
A 25-year-old woman was referred for cutaneous lesions
on the right leg, developing a month after she returned
from Mali. She had been diagnosed with Crohn's disease
at age 22, and was maintained in complete remission
under mesalazine. On physical examination, she had pus-
tular plaques of the right leg (figure 1), with two satellite
lesions of smaller size. There was no sign of digestive
relapse. She had already been treated with oxacilline (3 g/
day, 7 days), without any improvement. Clinical hypoth-
eses were Sweet's syndrome, pyoderma gangrenosum,
pustular psoriasis, bacterial or parasitic skin infection, and
mycetoma. Repeated bacteriological and mycological
investigations were negative. Skin histology showed a
lymphohistiocytic hypodermal infiltrate, associated with
non-caseating multinucleated giant cells granulomas (fig-
ure 2). Antimicrobial agents were discontinued, and
bethametasone dipropionate 0.05% cream was initiated.
The plaques decreased in size and infiltration by more
than 75% within 3 weeks.
Patient 2
A 51-year-old woman presented with papules of the
calves, evolving since 3 weeks. She had Crohn's disease
since the age of 21. A flare of Crohn's ileocolitis was devel-
oping for five months, with diarrhea and abdominal pain.
On clinical examination, she had asymptomatic, infil-
trated, erythematous and ulcerated, papules and plaques
of the calves, and a right keratoconjonctivitis. After clini-
cal examination, diagnostic hypotheses were Sweet's syn-
drome, erythema nodosum, pyoderma gangrenosum, and
mycobacterial, fungal or bacterial skin infection. Repeated
bacteriological and mycological investigations were nega-
tive. Histological examination showed a necrotizing vas-
culitis characterized by thromboses and necroses of
dermal blood vessels associated with a dermal infiltrate of
pycnotic neutrophilic granulocytes. The hypodermis
enclosed non-caseating epithelioid granulomata with
multinucleated giant cells consistent with a cutaneous
Crohn's disease. Ziehl, Grocott and PAS staining failed to
identify infectious agents. Considering the ongoing flare
of Crohn's ileocolitis, a systemic treatment was intro-
duced. The plaques decreased by more than 50% after 6
weeks of treatment with prednisolone (45 mg/day) and
azathioprine (100 mg/day).
Discussion
We here report two cases of cutaneous Crohn's disease,
where the diagnosis proved difficult due to the lack of spe-
cificity of the cutaneous clinical signs. In both cases, the
definite diagnosis was obtained – after ruling out an infec-
tious disease – by histology, which shows a granuloma-
tous infiltrate.
Cutaneous Crohn's disease was first described in 1965,
and was subsequently named "Metastatic Crohn's dis-
ease" in 1970 [7]. The ambiguous term "metastatic" –
which may unfortunately generate confusion with the
notion of "malignancy" – refers to the fact that skin
Anterior aspect of the right leg of patient 1: superficial ery- thematous ulcerated plaque, covered by pustules Figure 1
Anterior aspect of the right leg of patient 1: superficial ery-
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lesions are remote from the gastrointestinal tract, from
which they are separated by normal skin. Considering the
inflammatory nature of the disease, we – as others [7] –
emphasize that the term "metastatic" should be aban-
doned and replaced by "cutaneous".
Cutaneous Crohn's disease typically presents clinically as
dusky, erythematous, infiltrated, and sometimes ulcerated
plaques and nodules. Approximately two thirds of the
patients are female, and the mean age at onset is 34.5
(range: 5 – 71) [6]. Interestingly, there does not seem to
be any correlation between the intestinal and the cutane-
ous activity of Crohn's disease [6,7] as it was the case for
patient 1. These skin lesions are predominantly found in
the genital region and on lower extremities but have as
well been described on the face, the abdomen, the peri-
neum, the flexural areas (submammary folds, retroauricu-
lar region, groin, and abdominal folds) [6,8].
Given the variable topography and presentation, clinical
differential diagnoses are plentiful. Especially when gas-
trointestinal Crohn's disease has not been previously
identified, clinical diagnosis can be quite subtle. Con-
versely, even when gastrointestinal Crohn's disease has
been previously diagnosed, cutaneous Crohn's disease
can be clinically confused with various differential diag-
noses, such as pyoderma gangrenosum or mycobacterial
skin infections, that were both considered in our patients.
However, in all clinical contexts as in our observations,
establishing definite diagnosis requires the histological
examination of a skin lesion, which typically shows der-
mal and/or hypodermal non-caseating epithelioid granu-
lomata, with scattered multinucleated giant cells, and a
crown of peripheral lymphocytes and plasma cells. A
perivascular lymphomononuclear infiltrate may be asso-
ciated. Frequently, the consideration of a skin mycobacte-
rial or fungal infection greatly delays proper treatment; it
is of note that these infectious diseases may as well occur
during the course of Crohn's disease, either coincidentally
or as an effect of immunosuppressive therapies. Ruling
out infections, usually requires bacteriological and myco-
logical workup. In this context, the use of polymerase
chain reaction on a skin biopsy may help shorten the time
to exclude some infectious agents, including mycobacte-
ria.
The treatment of cutaneous Crohn's disease remains
unsatisfactory. Furthermore, its scarcity hampers thera-
peutic assessment in controlled trials. Thus, available lit-
erature is limited to case reports and sparse small series.
Successful treatments have been reported with métronida-
zole [8]. Contradictory results have been reported with
mesalazine [9], mycophenolate mofetil [10], steroids
[8,9], azathioprine [9], sulphasalazine [8], and infliximab
[9]. Surgical excision of the affected intestine seems not to
improve cutaneous Crohn's lesions. However, all these
reports are subject to publication bias, and no definitive
evidence-based statement can reasonably be made on the
most adequate management strategy for cutaneous
Crohn's disease. In our cases, corticosteroids administered
either topically or systemically were greatly efficient.
Conclusion
We here describe two cases of cutaneous Crohn disease of
the lower legs. A better knowledge of the possibility of dis-
tant Crohn manifestations should improve the delay of
adequate management of cutaneous complications of this
debilitating disease.
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Histological examination of a skin biopsy specimen of the  plaque showed on figure 1: lymphohistiocytic hypodermal  infiltrate, associated with non-caseating multinucleated giant  cells granulomas (Hematoxylin-eosin Strain; original magnifi- cation ×100) Figure 2
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